Filing Details
- Accession Number:
- 0000899243-20-014080
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-05-22 18:42:34
- Reporting Period:
- 2020-05-20
- Accepted Time:
- 2020-05-22 18:42:34
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1501134 | Invitae Corp | NVTA | Services-Medical Laboratories (8071) | 271701898 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1640322 | L Robert Nussbaum | C/O Invitae Corporation 1400 16Th Street San Francisco CA 94103 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-05-20 | 6,864 | $16.70 | 220,305 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-22 | 16,859 | $17.22 | 203,446 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-22 | 3,034 | $17.62 | 200,412 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Represents the sale of shares to cover tax withholding obligations associated with the vesting and settlement of restricted stock units.
- Represents a weighted average sale price. Actual sale prices ranged from $16.5068 to $17.0558 per share. Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
- Includes an aggregate of 144,490 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
- The sales of common stock were effected pursuant to a Rule 10b-5-1 sales plan adopted by the reporting person on March 17, 2020.
- Represents a weighted average sale price. Actual sale prices ranged from $16.56 to $17.55 per share. Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
- Represents a weighted average sale price. Actual sale prices ranged from $17.56 to $17.70 per share. Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
Billionaire Hedge Funds
